Yüklüyor......
Current and future pharmacologic treatment of nonalcoholic steatohepatitis
PURPOSE OF REVIEW: Nonalcoholic steatohepatitis (NASH), the aggressive form of nonalcoholic fatty liver disease (NAFLD), can progress to cirrhosis and hepatocellular cancer in 5–15% of patients and is rapidly becoming the leading cause for end-stage liver disease. Dietary caloric restriction and exe...
Kaydedildi:
| Yayımlandı: | Curr Opin Gastroenterol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5491795/ https://ncbi.nlm.nih.gov/pubmed/28346237 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOG.0000000000000356 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|